{
    "2021-08-05": [
        [
            {
                "time": "",
                "orginal_text": "江苏区域股市周报：利柏特跌出板块市值10强 158家机构调研天华超净",
                "features": {
                    "keywords": [
                        "利柏特",
                        "板块市值",
                        "机构调研",
                        "天华超净"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "金融",
                        "制造业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "orginal_text": "写意报告 | 中美临床试验申请的对比分析",
                "features": {
                    "keywords": [
                        "中美",
                        "临床试验",
                        "对比分析"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "orginal_text": "医药生物行业2021年下半年投资策略：创新+消费升级 引领行业成长",
                "features": {
                    "keywords": [
                        "医药生物",
                        "创新",
                        "消费升级",
                        "投资策略"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "orginal_text": "医药生物行业2021年8月投资策略：布局业绩确定 估值合理标的",
                "features": {
                    "keywords": [
                        "医药生物",
                        "业绩确定",
                        "估值合理",
                        "投资策略"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "orginal_text": "芯片界“药明康德”两日涨44%，市值重回500亿，蔡嵩松二季度加仓",
                "features": {
                    "keywords": [
                        "芯片",
                        "药明康德",
                        "市值",
                        "蔡嵩松",
                        "加仓"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "半导体",
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "又是“20cm”涨停！芯原股份近3个月股价翻倍",
                "features": {
                    "keywords": [
                        "20cm",
                        "涨停",
                        "芯原股份",
                        "股价翻倍"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "半导体",
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "刚刚，又是“20cm”涨停！芯片界“药明康德”炸了！总市值大超寒武纪，近3个月翻倍！诺安、南方加仓，华夏、博时、易方达等新进",
                "features": {
                    "keywords": [
                        "20cm",
                        "涨停",
                        "芯片",
                        "药明康德",
                        "市值",
                        "寒武纪",
                        "诺安",
                        "南方",
                        "华夏",
                        "博时",
                        "易方达"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "半导体",
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "北向资金加仓A股55亿，超20亿买入这个行业，继续抛售贵州茅台（名单）",
                "features": {
                    "keywords": [
                        "北向资金",
                        "加仓",
                        "A股",
                        "贵州茅台"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "消费",
                        "白酒"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "58股获券商买入评级，明新旭腾目标涨幅达85.74%",
                "features": {
                    "keywords": [
                        "券商",
                        "买入评级",
                        "明新旭腾",
                        "目标涨幅"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "汽车",
                        "制造业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "北向资金动向盘点：继续重手净买“电新、电子”",
                "features": {
                    "keywords": [
                        "北向资金",
                        "电新",
                        "电子",
                        "净买"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "新能源",
                        "电子"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "芯片界“药明康德”20cm涨停！盈利在望，诺安加仓",
                "features": {
                    "keywords": [
                        "芯片",
                        "药明康德",
                        "20cm",
                        "涨停",
                        "盈利",
                        "诺安",
                        "加仓"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "半导体",
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "速递 | 发现慢性肾病新靶点和新化合物，AI药物发现再获积极进展",
                "features": {
                    "keywords": [
                        "慢性肾病",
                        "新靶点",
                        "新化合物",
                        "AI药物发现"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物",
                        "AI"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "orginal_text": "速递 | 靶向DNA损伤响应机制，再鼎医药与Schrdinger合作开发抗癌疗法",
                "features": {
                    "keywords": [
                        "靶向",
                        "DNA损伤",
                        "再鼎医药",
                        "Schrdinger",
                        "抗癌疗法"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "orginal_text": "速递 | 合作打造靶向RNA的小分子药物，灵北剑指神经系统疾病",
                "features": {
                    "keywords": [
                        "靶向RNA",
                        "小分子药物",
                        "灵北",
                        "神经系统疾病"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}